Achieve Life Sciences Inc (ACHV): Next-Year EPS Estimate 53.60%
As of 2026-10-10, Achieve Life Sciences Inc (ACHV) has a next-year EPS growth estimate of 53.60%. Featured in our EPS revision report on 2026-08-19.
On 2026-09-29, analyst consensus for ACHV's next-year EPS growth shifted from 54.51% to 53.60% — a negative change of 0.91 percentage points. The revised estimate has been sustained across 12 subsequent trading sessions. Current-year growth is projected at -16.80%.
What's Driving This
Achieve Life Sciences shares have been rising primarily after analysts raised the next-year EPS growth estimate from 43.50% to 49.79% on 2026-08-13. That revision has continued, with the current next
Generated 2026-10-05 from news as of 2026-10-05
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 53.60%
- EPS growth this year
- -16.80%
- EPS next quarter (est)
- -$0.20
- Last price
- $7.41
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-10-10 | 53.60% | -16.80% | -$0.20 | $7.41 |
| 2026-10-09 | 53.60% | -16.80% | -$0.20 | $7.41 |
| 2026-10-08 | 53.60% | -16.80% | -$0.20 | $7.19 |
| 2026-10-07 | 53.60% | -16.80% | -$0.20 | $7.24 |
| 2026-10-06 | 53.60% | -16.80% | -$0.20 | $7.03 |
| 2026-10-05 | 53.60% | -16.80% | -$0.20 | $7.01 |
| 2026-10-04 | 53.60% | -16.80% | -$0.20 | $7.24 |
| 2026-10-03 | 53.60% | -16.80% | -$0.20 | $7.24 |
| 2026-10-02 | 53.60% | -16.80% | -$0.20 | $7.24 |
| 2026-10-01 | 53.60% | -16.80% | -$0.20 | $7.53 |
| 2026-09-30 | 53.60% | -16.80% | -$0.20 | $8.09 |
| 2026-09-29 | 53.60% | -16.80% | -$0.20 | $7.69 |
| 2026-09-28 | 54.51% | -16.72% | -$0.20 | $7.75 |
| 2026-09-27 | 54.51% | -16.72% | -$0.20 | $7.54 |
| 2026-09-25 | 54.51% | -16.72% | -$0.20 | $7.54 |
| 2026-09-24 | 54.51% | -16.72% | -$0.20 | $7.83 |
| 2026-09-23 | 54.51% | -16.72% | -$0.20 | $7.83 |
| 2026-09-22 | 54.51% | -16.72% | -$0.20 | $8.12 |
| 2026-09-21 | 54.51% | -16.72% | -$0.20 | $8.05 |
| 2026-09-20 | 54.51% | -16.72% | -$0.20 | $7.98 |
| 2026-09-18 | 54.51% | -16.72% | -$0.20 | $7.98 |
| 2026-09-17 | 54.51% | -16.72% | -$0.20 | $7.91 |
| 2026-09-16 | 54.51% | -16.72% | -$0.20 | $7.42 |
| 2026-09-15 | 54.51% | -16.72% | -$0.20 | $7.32 |
| 2026-09-14 | 54.51% | -16.72% | -$0.20 | $7.23 |
| 2026-09-13 | 54.51% | -16.72% | -$0.20 | $7.06 |
| 2026-09-11 | 54.51% | -16.72% | -$0.20 | $7.06 |
| 2026-09-10 | 54.51% | -16.72% | -$0.20 | $7.28 |
| 2026-09-09 | 54.51% | -16.72% | -$0.20 | $7.54 |
| 2026-09-08 | 54.51% | -16.72% | -$0.20 | $7.84 |
Reports Featuring ACHV
Recent News
- Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business UpdatesGlobeNewswire
- Achieve Life Sciences Inc (ACHV) Q1 2026 Earnings Call Highlights: Strategic Financing and ...GuruFocus.com
- Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona PharmaGlobeNewswire
- Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business UpdatesGlobeNewswire
- Achieve Life Sciences Inc (ACHV) Q4 2025 Earnings Call Highlights: Strategic Advances and ...GuruFocus.com
- Achieve Life Sciences Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their LossesNewsfile
- Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdatesGlobeNewswire
Screen Performance
Aggregate stats across all 2077 tickers our top-EPS-revision screen has flagged over the past 192 days.
- Median return since detection
- -0.9%
- % of tickers in the green
- 47%
- Median return on winners
- +23.2%
- Large revisions captured
- 1848
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Achieve Life Sciences Inc's next-year EPS growth estimate?▾
As of 2026-10-10, Achieve Life Sciences Inc (ACHV) has a next-year EPS growth estimate of 53.60%, based on analyst consensus.
When was the latest EPS estimate revision for ACHV?▾
The most recent revision occurred on 2026-09-29, when analysts adjusted the next-year EPS growth estimate from 54.51% to 53.60%.
What sector and industry does Achieve Life Sciences Inc belong to?▾
Achieve Life Sciences Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ACHV appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Achieve Life Sciences Inc (ACHV) appears here because it was detected by our daily top-EPS-revision-performer screen.